Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled “Why America Needs This Dangerous New Painkiller.” The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “”With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”
People
Related News
July 10, 2026
In the News
Nate Imfeld Receives Am Law 'Litigator of the Week' Shoutout for First Circuit Victory
Foley & Lardner LLP partner Nate Imfeld received a shout out in The Am Law Litigation Daily column for his recent appellate victory on behalf of Daimler Trucks North America.
July 10, 2026
In the News
James Bedotto and John Stern Generate Widespread Media Coverage For Foley Arrival
Foley & Lardner LLP partners James Bedotto and John Stern are featured across media for their recent arrivals to the firm.
July 9, 2026
In the News
Amy Ciepluch and Cullen Werwie Author Article on AI's Fiduciary Implications for 401(k) Plans
Foley & Lardner LLP attorneys Amy Ciepluch and Cullen Werwie authored the Practical Law article, “AI and 401(k) Plan Fiduciary Implications,” addressing AI in 401(k) plan management and key Employee Retirement Income Security Act (ERISA) fiduciary issues.